Alprostadil Shows Efficacy in Female Sexual Arousal Disorder - Medscape News

May 25, 2012 (Atlanta, Georgia) — A new formulation of alprostadil cream 0.4% (Femprox, Apricus Biosciences Inc), administered topically, significantly improved symptoms of female sexual arousal disorder (FSAD) in pre- and postmenopausal women, according ...

Female Sexual Arousal Disorder Improves with Cream - eMaxHealth.com

The women randomly received either placebo or 10 doses of alprostadil cream in one of three doses--500, 700, or 900 ug—which was applied to the external genitalia prior to sexual intercourse. In the original study, 33% of women in the placebo group ...

Apricus Biosciences Strengthens Vitaros and Nexact Patent Estate With Two New Patent Allowances - ad-hoc-news.de

About Vitaros(r) Vitaros(r) is a topically delivered formulation of alprostadil combined with the Company's proprietary NexACT(r) delivery technology for the treatment of erectile dysfunction (ED). The NexACT(r) delivery technology enhances the penetration ...

Apricus Biosciences Strengthens Vitaros(R) and Nexact(R) Patent Estate With Two New Patent Allowances - Yahoo Finance

Vitaros (R) is a topically delivered formulation of alprostadil combined with the Company's proprietary NexACT(R) delivery technology for the treatment of erectile dysfunction (ED). The NexACT(R) delivery technology enhances the penetration of ...

Apricus Biosciences Granted Regulatory Meeting With FDA for Femprox(R) for the Treatment of Female Sexual Arousal Disorder - Yahoo Finance

Femprox(R) is a topically applied formulation of 0.4% alprostadil delivered using Dodecyl 2-(N, N dimethylamino)-propionate (DDAIP), Apricus Bio's proprietary drug delivery technology. The Company believes that Femprox(R) is further along in ...

Apricus Biosciences Granted Regulatory Meeting With FDA for Femprox for the Treatment of Female Sexual Arousal Disorder - ad-hoc-news.de

Femprox(r) is a topically applied formulation of 0.4% alprostadil delivered using Dodecyl 2-(N, N dimethylamino)-propionate (DDAIP), Apricus Bio's proprietary drug delivery technology. The Company believes that Femprox(r) is further along in development ...

China Nuokang Bio-Pharmaceutical Inc. Forms Independent Committee and Appoints Independent Legal Counsel to Evaluate "Going Private" Proposal - Stockhouse

Nuokang's principal products include Baquting®, China's leading hemocoagulase product by market share; Kaitong®, a lipid emulsion alprostadil product for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post ...